Orthocell clears milestone for US launch of Remplir
Orthocell (ASX:OCC) has completed a pivotal US FDA 510(k) regulatory study for its nerve repair product, Remplir. This paves ...
Metcash battles hardware headwinds with food and liquor gains
Metcash (ASX:MTS) has reported results for the first half of FY25. The company delivered revenue growth, but faced challenges ...
California biofuel project aims to cut wildfire risk, but at what cost?
Critics question why South Stockton should shoulder the burden of increased air pollution so that others in the state can ...
yr.no1 天
Log Pool
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...